KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to -$10.7 million.

  • Medpace Holdings' Change in Account Payables fell 176197.92% to -$10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 22866.6%. This contributed to the annual value of -$3.0 million for FY2024, which is 38211.23% down from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Change in Account Payables is -$10.7 million, which was down 176197.92% from $1.3 million recorded in Q2 2025.
  • Medpace Holdings' Change in Account Payables' 5-year high stood at $10.7 million during Q1 2025, with a 5-year trough of -$10.7 million in Q3 2025.
  • In the last 5 years, Medpace Holdings' Change in Account Payables had a median value of $64000.0 in 2024 and averaged $404157.9.
  • As far as peak fluctuations go, Medpace Holdings' Change in Account Payables soared by 209330.99% in 2022, and later crashed by 176197.92% in 2025.
  • Over the past 5 years, Medpace Holdings' Change in Account Payables (Quarter) stood at -$284000.0 in 2021, then surged by 2093.31% to $5.7 million in 2022, then crashed by 65.17% to $2.0 million in 2023, then plummeted by 96.75% to $64000.0 in 2024, then crashed by 16857.81% to -$10.7 million in 2025.
  • Its Change in Account Payables was -$10.7 million in Q3 2025, compared to $1.3 million in Q2 2025 and $10.7 million in Q1 2025.